32398165|t|Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer's disease mice.
32398165|a|BACKGROUND: Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy, and irritability occur in prodromal phases of clinical Alzheimer's disease (AD), which might be an increased risk for later developing AD. Here we treated young APP/PS1 AD model mice prophylactically with serotonin-selective re-uptake inhibitor (SSRI) paroxetine and investigated the protective role of anti-depressant agent in emotional abnormalities and cognitive defects during disease progress. METHODS: To investigate the protective role of paroxetine in emotional abnormalities and cognitive defects during disease progress, we performed emotional behaviors of 3 months old APP/PS1 mouse following oral administration of paroxetine prophylactically starting at 1 month of age. Next, we tested the cognitive, biochemical and pathological, effects of long term administration of paroxetine at 6 months old. RESULTS: Our results showed that AD mice displayed emotional dysfunction in the early stage. Prophylactic administration of paroxetine ameliorated the initial emotional abnormalities and preserved the eventual memory function in AD mice. CONCLUSION: Our data indicate that prophylactic administration of paroxetine ameliorates the emotional dysfunction and memory deficit in AD mice. These neuroprotective effects are attributable to functional restoration of glutamate receptor (GluN2A) in AD mice.
32398165	0	10	Paroxetine	Chemical	MESH:D017374
32398165	33	54	emotional dysfunction	Disease	MESH:D003072
32398165	70	84	memory deficit	Disease	MESH:D008569
32398165	88	107	Alzheimer's disease	Disease	MESH:D000544
32398165	108	112	mice	Species	10090
32398165	126	151	Neuropsychiatric symptoms	Disease	MESH:D001523
32398165	153	156	NPS	Disease	MESH:D001523
32398165	166	176	depression	Disease	MESH:D003866
32398165	178	185	anxiety	Disease	MESH:D001007
32398165	187	193	apathy	Disease	
32398165	199	211	irritability	Disease	MESH:D001523
32398165	250	269	Alzheimer's disease	Disease	MESH:D000544
32398165	271	273	AD	Disease	MESH:D000544
32398165	330	332	AD	Disease	MESH:D000544
32398165	360	363	PS1	Gene	19164
32398165	364	366	AD	Disease	MESH:D000544
32398165	373	377	mice	Species	10090
32398165	400	409	serotonin	Chemical	MESH:D012701
32398165	420	429	re-uptake	Chemical	-
32398165	447	457	paroxetine	Chemical	MESH:D017374
32398165	523	546	emotional abnormalities	Disease	MESH:D000014
32398165	551	568	cognitive defects	Disease	MESH:D003072
32398165	641	651	paroxetine	Chemical	MESH:D017374
32398165	655	678	emotional abnormalities	Disease	MESH:D000014
32398165	683	700	cognitive defects	Disease	MESH:D003072
32398165	779	782	PS1	Gene	19164
32398165	783	788	mouse	Species	10090
32398165	822	832	paroxetine	Chemical	MESH:D017374
32398165	978	988	paroxetine	Chemical	MESH:D017374
32398165	1039	1041	AD	Disease	MESH:D000544
32398165	1042	1046	mice	Species	10090
32398165	1057	1078	emotional dysfunction	Disease	MESH:D003072
32398165	1130	1140	paroxetine	Chemical	MESH:D017374
32398165	1165	1188	emotional abnormalities	Disease	MESH:D000014
32398165	1235	1237	AD	Disease	MESH:D000544
32398165	1238	1242	mice	Species	10090
32398165	1310	1320	paroxetine	Chemical	MESH:D017374
32398165	1337	1358	emotional dysfunction	Disease	MESH:D003072
32398165	1363	1377	memory deficit	Disease	MESH:D008569
32398165	1381	1383	AD	Disease	MESH:D000544
32398165	1384	1388	mice	Species	10090
32398165	1486	1492	GluN2A	Gene	14811
32398165	1497	1499	AD	Disease	MESH:D000544
32398165	1500	1504	mice	Species	10090
32398165	Association	MESH:D000544	14811
32398165	Negative_Correlation	MESH:D012701	MESH:D017374
32398165	Negative_Correlation	MESH:D017374	14811
32398165	Negative_Correlation	MESH:D017374	MESH:D000544
32398165	Negative_Correlation	MESH:D017374	MESH:D003072
32398165	Association	MESH:D008569	14811
32398165	Negative_Correlation	MESH:D017374	MESH:D000014
32398165	Negative_Correlation	MESH:D017374	MESH:D008569

